Rokos Capital Management (UK)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-179,840
Closed -$4.23M – 85
2022
Q4
$4.23M Buy
179,840
+39,840
+28% +$1.07M 0.19% 46
2022
Q3
$3.75M Hold
140,000
– – 0.11% 64
2022
Q2
$4.66M Hold
140,000
– – 0.14% 60
2022
Q1
$10.2M Buy
+140,000
New +$10.1M 0.48% 34

Other funds holding TDOC

Rokos Capital Management (UK)'s TDOC Position: Q1 2023 in Review

Rokos Capital Management (UK) sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 179,840 shares — an estimated $4.23M sold.

Rokos Capital Management (UK) first reported a position in TDOC in Q1 2022 and held it in 4 quarters. The position peaked at $10.2M in Q1 2022. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Rokos Capital Management (UK) reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 179,840 Teladoc Health shares in Q1 2023, an estimated $4.23M.
  • Rokos Capital Management (UK) first reported a position in Teladoc Health in Q1 2022 and held it in 4 quarters.
  • Rokos Capital Management (UK)'s Teladoc Health position peaked at $10.2M in Q1 2022.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Rokos Capital Management (UK)'s 13F filing for Q1 2023, filed 15 May 2023.